NCT07176988

Brief Summary

This research study aims to evaluate the effect of treatment delivery method on voice outcomes over 12 months in people with a primary complaint of a voice problem, diagnosed with either non-phonotraumatic vocal hyperfunction, also known as primary muscle tension dysphonia (MTD) or phonotraumatic vocal hyperfunction, also known as benign vocal fold lesions (lesions). The secondary objectives are:

  • To evaluate acoustic correlates of clear speech and the relationship to vocal acoustic and patient-reported voice outcomes.
  • To determine the association between overall dysphonia outcomes and adoption of clear speech.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
36mo left

Started Sep 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Sep 2025Apr 2029

First Submitted

Initial submission to the registry

August 18, 2025

Completed
16 days until next milestone

Study Start

First participant enrolled

September 3, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 16, 2025

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2029

Last Updated

October 20, 2025

Status Verified

October 1, 2025

Enrollment Period

3.6 years

First QC Date

August 18, 2025

Last Update Submit

October 15, 2025

Conditions

Keywords

Conversation Training TherapyHierarchical Conversation Training Therapyprimary muscle tension dysphoniabenign vocal fold lesions

Outcome Measures

Primary Outcomes (2)

  • Change in Voice Handicap Index-10 (VHI-10) score

    The Voice Handicap Index-10 (VHI-10) is a 10-question survey used to measure how much a voice problem affects a person's daily life. Scores range from 0 to 40, with higher scores indicating a greater perceived voice handicap. Each item is rated from 0 ("never") to 4 ("always") A higher score means greater voice-related disability as perceived by the patient.

    During intervention (4 week period of active treatment: Week 1, Week 2, Week 3, Week 4) immediately post treatment ( week 5), 3month, 6 month and 12-months post treatment

  • Change in vowel space

    Change in vowel space refers to alterations in the acoustic range of vowel production-specifically, how far apart vowels are from each other in the formant frequency space (typically plotted as F1 vs F2, the first and second formants). It reflects the clarity, precision, and distinctiveness of vowel articulation during speech. Vowel space will be measured through acoustic analysis of participants' spoken sentences from the Sentence Intelligibility Test (SIT). These sentences include both corner vowels (e.g., heed, had, hod, who'd) and non-corner vowels (e.g., hid, head, hut, hood), allowing for detailed tracking of articulatory patterns

    During intervention (4 week period of active treatment: Week 1, Week 2, Week 3, Week 4) immediately post treatment ( week 5), 3month, 6 month and 12-months post treatment.

Secondary Outcomes (13)

  • Auditory- Perceptual severity

    Baseline , 3 month, 6 month, 12 month

  • Stroboscopic changes: Glottal Closure

    Baseline, Post intervention (1 week), 3 month, 6 month, 12 month

  • Stroboscopic changes: Amplitude

    Baseline, Post intervention (1 week), 3 month, 6 month, 12 month

  • Stroboscopic changes: Mucosal Wave

    Baseline, Post intervention (1 week), 3 month, 6 month, 12 month

  • Stroboscopic changes: Free edge contour

    Baseline, Post intervention (1 week), 3 month, 6 month, 12 month

  • +8 more secondary outcomes

Study Arms (2)

Non-Hierarchical Conversation Training Therapy (CTT)

EXPERIMENTAL
Other: Non Hierarchical method

Hierarchical Conversation Training Therapy (CTT-H)

EXPERIMENTAL
Other: Hierarchical method

Interventions

Participants in the hierarchical version of Conversation Training Therapy (CTTH) will receive four weekly sessions of voice therapy. This approach gradually increases the difficulty of speaking tasks-from simple sounds to full conversations-based on the participant's progress. The therapy begins with basic awareness and speech sounds (e.g., consonant-vowel pairs), then progresses through words, phrases, and sentences, culminating in natural conversation. Each level must be completed with at least 80% accuracy before proceeding to the next one. The structure is modeled after traditional voice therapies like resonant voice and aims to help participants succeed early and reduce mental fatigue. Daily homework includes seven short (2.5-minute) practice sessions, aligned with prior research showing this is a realistic and effective amount of practice.

Hierarchical Conversation Training Therapy (CTT-H)

The therapy includes four weekly sessions and several key techniques: Clear Speech: Speaking clearly, like leaving an important voicemail. Awareness Training: Paying attention to how the voice sounds and feels in the mouth and face. Negative Practice: Switching between their "bad" voice and "good" therapy voice to recognize and improve differences. Embedded Gestures: Briefly holding certain speech sounds to reduce vocal strain and boost clarity. Prosody and Projection: Working on pitch, rhythm, and speaking louder through better technique. Participants practice these skills throughout the day using a mobile app to track their progress and record a weekly sample. Unlike hierarchical models, components in CTT can be introduced in any order based on individual needs, making it flexible and personalized

Non-Hierarchical Conversation Training Therapy (CTT)

Eligibility Criteria

Age16 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Non-smoking
  • Diagnosis of either primary muscle tension dysphonia of the hyperadducted type or benign vocal fold lesions.
  • No neuro-laryngologic or age-related vocal fold changes (e.g., atrophy)
  • No history of voice therapy or voice surgery in the last year
  • No history of other serious chronic medical conditions that may affect voice (per patient report), Normal hearing (determined by pure tone audiometry), stimulable and appropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist,
  • Willingness to attend all therapeutic interventions and follow-up sessions
  • Willingness to use a smartphone to record practice

You may not qualify if:

  • History of voice therapy or voice surgery in the last year
  • Serious chronic medical condition that may affect voice (per patient report)
  • Abnormal hearing ability (despite appropriate amplification)
  • Other laryngeal disorders not attributed to primary MTD and benign vocal fold lesions,
  • Not stimulable or inappropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist
  • Unwillingness to attend therapeutic intervention and follow-up sessions
  • Unwillingness to use a smartphone to record practice
  • Pregnant women
  • Prisoners
  • Cognitive impairment or impaired decision-making capacity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory Voice Center at Emory University Hospital Midtown

Atlanta, Georgia, 30308, United States

RECRUITING

MeSH Terms

Conditions

Dysphonia

Condition Hierarchy (Ancestors)

Voice DisordersLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Amanda Gillespie, PhD

    Emory University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amanda Gillespie, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Subjects will be assigned based on a stratified block randomization based on diagnosis (MTD, lesions), severity (mild, moderate, severe), and sex
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 18, 2025

First Posted

September 16, 2025

Study Start

September 3, 2025

Primary Completion (Estimated)

April 1, 2029

Study Completion (Estimated)

April 1, 2029

Last Updated

October 20, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

This project will generate multi-modal data from 120 participants with voice disorders, including acoustic, aerodynamic, perceptual, and imaging data (\\\~30GB .wav/.nsp files; 135GB laryngeal videos), patient-reported outcomes (\\\~50MB REDCap exports), therapy session videos (\\\~2TB .mp4 files), and practice audio files. Core data (e.g., VHI-10 scores, voice outcomes) will be stored and shared via the Open Science Framework (OSF), adhering to NIH FAIR data principles. Files \<3MB (e.g., protocols, VHI-10 raw data) may be included in publications as appendices.

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
Datasets will be uploaded to OSF within 6 months of their collection, beginning 4 months after the award begins
Access Criteria
Acoustic, aerodynamic, visual, and auditory perceptual and patient-reported outcomes data will be made available on the Open Science Framework Repository. This repository is an open-access, free platform designed for data preservation and sharing. De-identified datasets and metadata will be publicly accessible through this repository. PI will maintain up-to-date ORCID records with persistent unique identifiers such as DOIs for publications and funder IDs to assist findability. DOIs will be searchable in the Open Science Framework Repository.

Locations